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was	 then	 inflated	 to	 220	 mmHg	 for	 5	 minutes	 immediately	 distal	 to	 the	
antecubital	 fossa.	 Following	 release	 of	 the	 cuff,	 the	 artery	 was	 imaged	
continuously	for	five	minutes	(FMD).	After	a	further	15	minutes	of	rest,	the	artery	
was	again	imaged	for	60	seconds.	Subjects	were	then	given	25	µg	of	sublingual	
nitrate	 and	 the	 radial	 artery	 imaged	 for	 continuously	 for	 a	 further	 5	minutes	
(NMD).	
	








Images	 were	 analysed	 offline	 using	 proprietary	 software	 (Brachial	 Analyser,	
Vascular	Tools,	Medical	Imaging	Applications,	USA).	Baseline	and	peak	diameters	
were	measured	in	millimetres	with	measurements	averaged	across	sixty	frames	
and	 ten	 frames	 for	 baseline	 and	 peak	 values	 respectively.	 Flow-mediated	





Coronary	 angiography	 was	 performed	 via	 the	 right	 radial	 artery	 in	 all	 cases.	




at	operator’s	discretion	 if	 follow-on	percutaneous	 coronary	 intervention	 (PCI)	
was	undertaken).	Arterial	sheaths	were	removed	at	the	end	of	the	procedure	with	
haemostasis	achieved	using	a	TR	bandTM	(Terumo,	Japan).	In	a	subset	of	patients	


























































































scatter	 profile.	 Expression	 of	 each	 surface	 marker	 was	 then	 determined	
individually	 and	 co-expression	 was	 determined	 using	 Boolean	 principles.		




























































































































































































































































































































































































































Age		 		61±	9	 22±4	 69±9	
Female	(%)	 		15	(75)	 13	(65)	 3	(30)	
Heart	Rate	 		62±10	 		70±12	 64±9	
Systolic	Blood	Pressure	 		138±12		 		118±9	 135±17	
Smoker	(%)	 		4	(20)	 0	(0)	 3	(30)	
Coronary	artery	disease	(%)	 		18	(90)	 0	(0)	 7	(70)	
Diabetes	(%)	 		4	(20)	 0	(0)	 2	(20)	
Hypertension	(%)	 		15	(75)	 0	(0)	 90	(90)	























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Research protocol materials 
 
 
Substitutions unsuccessfully trialled 
 







(Ficollpaque PlusTM, GE, US) 
 
No additional substitutions trialed 
 
 
GMP Grade FICOLL (FiccollPaquePREMIUMTM, GE, 
US) 
 






Rat-tail Collagen type I 
 
CellstartTM (Thermofisher,  US) 
 
 













Human albumin serum (Sigma-Aldrich, 
US) 
 
Xerum-FreeTM (Funakoshi, Japan) 
 
GMP-grade customized EBM-2 (Lonza, US) media with 
EGM-2 Singlequot kit  
Without heparin 
With clinical grade insulin (Lilly, UK) 
 


























































































































































































Diabetes	 	 4	(67%)	 2	(67%)	 3	(75%)	
Current	
smoker	
	 1	(17%)	 0	(0%)	 0	(0%)	
Family	
history	















































research-grade	materials.	There	was	 no	 difference	 in	 proliferation	 between	
EOCs	cultured	using	our	established	research-grade	materials	(Rat	tail	collagen	I	
and	Hyclone	 fetal	calf	 serum,)	and	 those	with	human	AB	serum	or	PurecoatTM	
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PET CT of  radial and coronary arteries
n=24n=6
N=12N=12n=3 N=3
Intra-arterialIntra-venous
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arterial	sheath	in	situ.	The	field	of	view	will	be	adjusted	to	include	both	radial	
arteries	and	the	patient’s	heart.	According	to	study	group	allocation	cells	or	free	
18F-FDG	will	be	injected	either	intra-venously	or	intra-arterially	via	the	radial	
arterial	sheath.	The	arterial	sheath	will	be	withdrawn	immediately	following	
cell	or	tracer	injection	and	haemostasis	will	be	achieved	using	a	haemostatic	
band	(TR	bandTM	Terumo,	Japan).	
	
Dynamic	PET	Imaging	will	then	be	carried	during	the	60	minutes	from	injection	
and	a	further	late	imaging	point	will	assess	cellular	distribution	at	3	h.		Study	
outcomes	will	be	the	maximum	standard	uptake	value	in	the	catheterised	radial	
artery	and	stented	segments	of	coronary	artery	with	comparisons	made	with	
the	contra-lateral	radial	artery	and	non-stented	segments	of	coronary	artery	
respectively,	comparisons	will	also	be	made	between	study	groups.	Dynamic	
imaging	will	be	used	to	construct	time-activity	curves	for	regions	of	interest	in	
the	radial	and	coronary	arteries	to	examine	the	differences	in	distribution	of	
activity	between	injections	of	labelled	cells	and	free	18F-FDG.	
	
Preliminary	experience	of	intra-radial	administration	of	free	FDG	confirms	that	
we	can	see	a	clear	signal	in	the	radial	artery	using	5MBq	of	which	is	an	
approximation	of	the	activity	we	would	anticipate	administering	which	our	
labelled	cells.	Figure	2.		
	
This	study	aims	to	define	the	biodistribution	of	EOCs	when	administered	in	man	
and	answer	the	question	as	to	whether	they	are	able	to	localise	to	areas	of	
	 199	
vascular	injury.	If	this	localisation	is	demonstrated	it	will	provide	us	with	a	
plausible	mechanism	by	which	these	cells	could	affect	vascular	regeneration	
and	form	the	basis	for	therapeutic	trials	in	acute	and	chronic	ischaemic	
conditions.	
	
	
	
	
Figure	2:	Fused	PET-CT	image	of	the	radial	artery	following	intra-arterial	
administration	of	free	FDG	(5MBq).	
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8.4.2	Development	of	the	radial	artery	as	a	model	of	mechanical	injury	
	
We	studied	the	radial	artery	post-catheterisation	to	examine	cellular	profiles	
surrounding	vascular	injury	and	to	characterise	an	injury	model	to	be	used	in	
future	cell	tracking	studies	but	there	are	potential	alternatives	for	the	model.	
The	variability	of	the	technique	of	flow-mediated	dilatation	(Brook	et	al.	2005;	
Mitchell	et	al.	2016)	makes	it	difficult	to	use	this	model	to	test	therapeutic	
interventions,	although	this	has	been	trialled	with	success	in	the	past	(Park	et	al.	
2012).	
	
Vascular	injury	and	specifically	plaque	rupture	is	a	phenomenon	of	daily	
relevance	to	clinical	cardiology.	Whilst	the	advent	of	ultra-high	sensitivity	
troponin	assays	has	dramatically	improved	our	ability	to	detect	myocardial	
injury	(Shah	et	al.	2015),	frequent	referrals	with	hyper-troponinaemia	of	
uncertain	significance	mean	that	a	more	specific	marker	of	endothelial	
disruption	and	thus	plaque	rupture	would	be	valuable.		Using	the	radial	artery	
in	elective	cardiac	catheterisation	could	be	a	useful	model	of	discrete	and	
defined	vascular	injury	which	may	be	useful	in	biomarker	development.	
	
Intra-vascular	imaging	of	the	radial	artery	with	OCT	could	define	the	extent	of	
arterial	injury	sustained	at	catheterisation	(microscopic	endothelial	disruption	
could	be	assumed	as	a	minimum	given	our	experience)	and	sampling	of	arterial	
blood,	ipsilateral	venous	outflow,	with	comparison	to	the	contra-lateral	arms	
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for	levels	of	putative	markers	in	response	to	a	well-defined	vascular	injury	
could	be	undertaken.	
	
8.4.3	Trials	of	endothelial	outgrowth	cells	as	a	therapy		
	
Trials	of	cell	therapy	in	ischaemic	and	non-ischaemic	cardiomyopathy	to	date	
have	largely	employed	either	peripheral	blood	mononuclear	cells	or	CD34+	cells,	
with	meta-analyses		suggesting	a	potential	benefit	but	firm	conclusion	being	
precluded	by	imperfect	study	designs	or	small	sample	sizes	(Fisher	et	al.	2015;	
Lu	et	al.	2016).	It	may	be	that	these	cells	are	not	able	to	differentiate	into	
cardiomyocytes	as	readily	as	previously	described	(Yeh	et	al.	2003)	and	various	
less	naïve	cell	populations	are	currently	under	trial	as	regenerative	therapies	
(Sanz-Ruiz	et	al.	2017).	Given	they	represent	a	more	differentiated	population,	
late	outgrowth	cells	may	be	an	agent	for	myocardial	regeneration.	Whilst	EOCs	
would	not	be	expected	to	differentiate	into	cardiomyocytes,	they	do	incorporate	
into	host	vessels	and	improve	perfusion	and	therefore	may	support	cardiac	
regeneration,	perhaps	in	combination	with	cardiac	progenitor	cells.	
	
Peripheral	arterial	disease	is	another	area	of	interest	in	regenerative	medicine	
and	trials,	once	again	largely	using	peripheral	blood	mononuclear	cells	or	CD34+	
cells	have	generally		been	more	promising	than	in	cardiac	regeneration	(Rigato	
et	al.	2017).	Given	their	convincing	capacity	to	augment	angiogenesis	in	
experimental	models	of	limb	ischaemia	(Goto	et	al.	2016;	Minami	et	al.	2015;	
Dauwe	et	al.	2016)	EOCs	may	be	a	useful	therapy	in	peripheral	vascular	disease.	
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Our	GMP-compliant	manufacture	protocol	would	allow	us	to	test	these	cells	in	
man	should	our	initial	cell	tracking	study	be	successful.	
	
8.5	CLINICAL	PERSPECTIVE	
	
Despite	the	advances	made	in	medical,	surgical	and	percutaneous	treatment,	
cardiovascular	diseases	continue	to	cause	huge	morbidity	and	mortality.	The	
prospect	of	regenerating	either	the	vasculature	or	myocardium	is	enticing	and	
cellular	therapy	promises	to	have	a	genuine	impact	on	these	conditions.	To	date	
however,	the	benefits	of	these	therapies	appear	marginal	and	the	positive	
results	seen	in	experimental	work	have	yet	to	be	replicated	in	the	clinical	arena.	
	
Cell	therapy	trials	have	largely	employed	non-specific	cell	populations	and	it	
may	be	that	the	heterogeneity	of	the	cells	administered	has	reduced	the	efficacy	
of	these	therapies.		It	is	possible	that	the	use	of	more	lineage	specific	cells	than	
those	used	to	date	will	be	more	fruitful.	Late-outgrowth	endothelial	cells	are	
highly	proliferative,	have	been	shown	to	incorporate	into	host	vessels	and	
contribute	to	angiogenesis	in	animal	models	of	ischaemia.		As	such	they	are	a	
promising	potential	agent	for	vascular	regeneration	in	chronic	ischaemic	
conditions.		
	
Given	the	logistical	and	financial	commitment	involved	in	a	clinical	trial	of	a	
cellular	therapy,	it	will	be	important	to	establish	biofeasibility	by	demonstrating	
localisation	of	EOCs	to	areas	of	vascular	injury.	By	administering	radiolabelled	
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EOCs	in	the	context	of	transradial	cardiac	catheterisation	we	hope	to	
demonstrate	homing	of	these	cells	to	areas	of	endothelial	denudation	and	
confirm	that	EOCs	are	indeed	a	plausible	agent	for	vascular	regeneration	in	
man.	If	shown	to	home	to	areas	of	endothelial	disruption	in	this	model,	then	a	
therapeutic	trial	of	EOCs	is	a	realistic	and	logical	next	step.	Whilst	re-
endothelialisation	of	the	radial	artery	following	cardiac	catheterisation	is	not	a	
clinical	problem	which	needs	to	be	addressed	in	cell	therapy	trials,	intra-arterial	
or	intra-muscular	administration	of	EOCs	in	chronic	ischaemic	disease	of	the	
peripheral	or	coronary	circulation	may	prove	fruitful.	
	
In	summary,	we	have	demonstrated	the	utility	of	the	radial	artery	as	a	model	of	
vascular	injury	and	established	a	protocol	for	culturing	and	labelling	EOCs	in	a	
GMP-compliant	manner	which	will	allow	us	to	perform	cell	tracking	studies	to	
define	their	behaviour	in	vivo	in	man.	
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